University of California San Francisco

Give to UCSF
Advanced
433 Results in the UCSF News Center
Type of Article
Areas of Focus
Date of Publication
Health And Science Topics
Campus Topics

New kidney transplant drug effective in humans, UCSF study finds

UCSF nephrologist Flavio Vincenti, MD, is the lead author of a paper in the March 2010 issue of the <i>American Journal of Transplantation</i> that reports results from a Phase III clinical trial for a new drug that selectively blocks immune suppression for kidney transplants. The drug, belatacept, is given to kidney-transplant recipients to prevent the immune system from rejecting the new organ. Vincenti and his co-investigators found that belatacept may be as effective as the commonly used anti-rejection drug cyclosporine, but with fewer side effects and superior kidney function after 12 months.

Placeholder image

UCSF conference to focus on therapeutics of the future

Some of the leading scientists in bioengineering, nanotechnology and pharmaco-genomics will gather on Tuesday, January 26, 2010 to discuss how to harness the tools of these emerging fields to develop new diagnostics and treatments for complex diseases.

Placeholder image

UCSF-Fresno to offer free medication consultations for public

The UCSF School of Pharmacy&#8217;s Medication Management Program in Fresno will be offering free consultations with professional clinical pharmacists on two consecutive Tuesdays in January. The service is free of charge and open to anyone with diabetes, those who take blood thinners or people taking three or more medications.

Placeholder image